UnitedHealth Group (NYSE:UNH) stock rose 2.3% after the healthcare giant reaffirmed its previously disclosed 2025 earnings outlook during investor meetings scheduled for this week.
The company disclosed in an SEC filing that senior leaders will be meeting with investors and analysts between September 8-10, during which they plan to stand by the adjusted earnings per share expectations that were initially shared on July 29.
UnitedHealth noted that its outlook factors in the acquisition of Amedisys, which closed in August 2025. The company expects this acquisition to be "modestly dilutive" to adjusted earnings per share due to financing costs and integration-related investments.
The meetings with investors may also include discussions about UnitedHealth’s strategy, market positions, and recent results that have been previously disclosed, according to the filing.
The positive market reaction suggests investors are encouraged by the company’s confidence in maintaining its earnings guidance despite the short-term financial impact of the Amedisys acquisition.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.